President's Welcome
Mission/Vision
Leadership
Special Service Awards
Press Releases
FAQ
Southern Medical Journal
CME Calendar
CME Online Library
Request a Brochure
Rate Your Practice
Practice Performance
Physician Relations
Financial Management
Physician Recruitment
Career Center
Physician Compensation
Practice Management Boot Camp
Online Resources
New Program Development
Physicians Group Purchasing
SMA Tours
Insurance
Resident and New Physicians Insurance Program
Financial Services
Retirement
MBNA
Paychex
Table of Contents
Featured CME Articles
Invitation to Reviewers
Reprint Information
Osteoporosis Bone Buzz
Practice Management
New Physicians Travel Benefit Program
Your Place In Today's Medicine Seminar
Physician Mentoring Program
Research & Endowment
Society of 1906
 
SMA: Southern Medical Association
HomeLoginJoin/RenewSite Map SMA ServicesSMA Alliance
 

 




Return to Topic Area:
Welcome Page
 
Search
 E-Mail to a colleague
Modern Medicine - A New Resource for Busy Physicians & Healthcare Professionals
Click Here to Learn More

Clinician to Clinician: Have you ruled out a placental site nodule?
Source: Contemporary OB/GYN
By: Ie-Ming Shih, MD., Ruchi Garg, MD., Robert E. Bristow, MD., James J. Russell, MD.
Originally published: December 1, 2004

Recently while performing a tubal ligation, we noted that the patient had a dilated fallopian tube. During surgery, our differential diagnosis included chronic ectopic pregnancy, hydro- or pyosalpinx, complex cyst, and tumor. But the pathology report showed that the dilation was caused by a placental site nodule. Such nodules usually are incidental findings in uterine curettings, cervical biopsies, or some hysterectomy specimens because they do not produce symptoms and there are no lab studies on which to base a diagnosis. While some cases require follow up, others do not.

Details of the case Our patient was a 29-year-old gravida 5, para 2 who was using depot medroxyprogesterone acetate for contraception at the time she was scheduled for bilateral tubal ligation. She was healthy with no complaints and had been a heavy smoker. She'd had one full-term spontaneous vaginal delivery, followed by a primary cesarean delivery at term, necessitated by preeclampsia, and a VBAC at 36 weeks. The patient had a history of three D&Cs; two for spontaneous abortions in the first trimester and one for therapeutic abortion. She began menstruating at age 10 and she had a history of regular cycles until the injectable contraceptive made her amenorrheic. She had no reported history of sexually transmitted diseases and had a normal abdominal, pelvic, and rectal examination. Laboratory data were unremarkable, including negative qualitative human chorionic gonadotropin assay and cervical cultures, normal Pap, and normal white blood count.

The patient underwent bilateral partial salpingectomy via mini-laparotomy. At surgery, we saw a normal left fallopian tube and ovary with very few thin adhesions, which were easily ligated. Approximately 1.5 cm of the right fallopian tube, at the midpoint, was distended. Its tan color and fusiform shape made it look like a small ectopic pregnancy. Most of the tube, including the dilated segment, was resected. The tubal content was light chocolate-brown in color, like a hematosalpinx. The pathology report showed a normal left fallopian tube and a peritubal placental site nodule in the right fallopian tube.


FIGURE 1. Placental site nodule in the fallopian tube. Small, well-circumscribed nodular aggregates of chorionic-type intermediate-type cells are surrounded by a thin rim of chronic inflammatory cells and occasionally decidual cells, embedded in a hyalinized stroma. (Hematoxylin and eosin, original magnification, x10.)
Recognizing a placental site nodule Placental site nodules are considered a form of gestational trophoblastic disease (GTD), which is a group of lesions derived from the conceptus and not from the patient. GTDs include molar and non-molar lesions. Placental site nodules are non-molar, derived from villous intermediate trophoblasts.1

On histology, the nodules contain small, haphazardly arranged trophoblastic cells; some of the cells have clear cytoplasm and others have eosinophilic cytoplasm (Figure 1).2,3 Nodules that are grossly visible usually are well-circumscribed, yellow excrescences confined to the endometrium, endocervix, or—as in our case—to the fallopian tube. They can range in size from 1 to 14 mm (average 2.1) and in occasional cases there is more than one.4

As benign lesions, placental site nodules do not invade the endomyometrium or blood vessels. They can, however, develop into epithelioid trophoblastic tumors, but research thus far shows that to be rare. There are also no documented cases of recurrence of such nodules, or of associated epithelioid trophoblastic tumors.3

Like our patient, many women with placental site nodule are of reproductive age with a history of pregnancies, therapeutic abortions, and C/S; a significant number also have a history of tubal ligation.4 At the time of diagnosis, most patients are not pregnant. It's not clear whether a placental site nodule is derived from the persistence of trophoblast associated with a pregnancy that preceded a tubal ligation or from a new gestation that follows an unsuccessful tubal ligation.4 It may be a remnant of the placental site that failed to completely involute or arise de novo from an abnormal "blighted" gestation that never fully developed.1,3 Placental site nodules are distinguished from trophoblastic tumors by their small size, superficial location, circumscription, extensive hyalinization, and rare-to-absent mitotic activity. The tumors typically are diagnosed in patients who are clinically thought to have had a missed abortion. It's important to distinguish between the two lesions because there is evidence that a placental site trophoblastic tumor has malignant potential.2

No specific treatment or follow-up is necessary for placental site nodule since the condition has neither been shown to recur locally nor to progress to persistent GTD.1 However, the next time you encounter a fallopian tube lesion, consider including placental tube nodule in your differential diagnosis.

REFERENCES 1. Shih IM, Kurman RJ. Molecular basis of gestational trophoblastic diseases. Curr Mol Med. 2002;2:1-12.

2. Santos LD, Fernando SS, Yong JL, et al. Placental site nodules and plaques: a clinicopathological and immunohistochemical study of 25 cases with ultrastructural findings. Pathology. 1999;31:328-336.

3. Shih IM, Seidman JD, Kurman RJ. Placental site nodule and characterization of distinctive types of intermediate trophoblast. Hum Pathol. 1999;30:687-694.

4. Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol. 2001;20:31-47.








CLINICIAN to CLINICIAN offers the hard-won wisdom and expertise of physicians "in the trenches." We're looking for unusual case reports, anecdotes about innovative treatments, and practical solutions for professional problems from community physicians. Send your submission of 750 words or less to Editor in Chief Charles J. Lockwood, MD, by e-mail
, fax (973-847-5340) or mail (5 Paragon Drive, Montvale, NJ 07645). All submissions are subject to peer review by theContemporary OB/GYN Editorial Board. Nevertheless, the concepts discussed may be anecdotal in nature.



 E-Mail to a colleague
A new resource for time-starved physicians and healthcare professionals
Modern Medicine - Click Here
Search
Return to Topic Area:
Welcome Page
 


Privacy Policy Disclaimer Copyright Editorial Policy Sponsorship Policy All Topics
   Powered by Mediwire
Copyright © 2005
Southern Medical Association
35 Lakeshore Drive
Birmingham, AL 35209
Tel: 800-423-4992
205-945-1840
Disclaimer | Privacy Policy
Website Advertising Policy